The researchers compared hospitalized COVID-19 patients with influenza patients treated in 2018.

Foldax, a Salt Lake City-based healthcare company focused on heart valve technology, has closed a $20 million Series D round of financing.

The protein was designed to prevent cell death through the disruption of two specific Kv2.1 channels.

CMS has proposed expanding its national coverage policy for transcatheter edge-to-edge repair of the mitral valve so that it includes patients with functional mitral regurgitation. 

Rapid reperfusion is linked to improved survival for STEMI patients, but delayed care is still prevalent. 

The report comes as confirmed cases continue to rise in certain parts of the country. If that surge continues, the pandemic's financial impact “could be even more significant.”

COVID-19 has the potential to infect cardiac cells, causing changes in their ability to function after just 72 hours. 

Statin use may help healthy older patients avoid physical disability and cardiovascular disease, according to new data published in the Journal of the American College of Cardiology.

The analysis, published in Stroke, gathered data from two massive patient registries in China. 

COVID-19 has disrupted routine cardiovascular care all over the world, with some procedures getting delayed for months and many hospitals reporting a significant drop in myocardial infarction patients.

Dwight I. Peretz, MD, had a long career in cardiology, but he also lived an unforgettable childhood, one that included delivering undercover messages in Japanese-occupied Shanghai.

The study's authors tracked data from more than 2 million women.